K. Denaxas

The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial

G. Karamanolis, P. Sfikakis, S. Ladas, 2016, Arthritis Research & Therapy.

Beneficial effect of the 5-HT1A receptor agonist buspirone on esophageal dysfunction associated with systemic sclerosis: A pilot study

G. Karamanolis, P. Sfikakis, S. Ladas, 2015, United European gastroenterology journal.

Evaluation and management of esophageal manifestations in systemic sclerosis

G. Karamanolis, S. Ladas, K. Denaxas, 2018, Annals of gastroenterology.

Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the management of noncardiac chest pain

G. Karamanolis, M. Galanopoulos, G. Mantzaris, 2017, European journal of gastroenterology & hepatology.